PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT07217509
Status
Enrolling By Invitation

Conditions

  • Myasthenia Gravis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The design is a prospective, observational (non-interventional) registry for subjects with myasthenia gravis under the care of a neurology provider. Longitudinal data are collected from both subjects and their treating neurology provider during routine clinical encounters using a structured and standardized data collection method. Approximately 1,500 myasthenia gravis subjects with no defined upper limit and 50 clinical neurology sites will be recruited.

Key Dates

Start date
Aug 14, 2025
Status verified
Oct 2025
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

MG epidemiology [ Time Frame: Every 6 months for 10 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By research site
CorEvitas, LLC· Waltham, MA

Related Studies